Genmab buys ProfoundBio for US$ 1.8 bn; FDA okays Vanda’s Fanapt to treat bipolar disorder
April kicked off with Danish drugmaker Genmab buying ProfoundBio for US$ 1.8 billion in cash. ProfoundBio is a clinical stage b...
Impressions : 1141
Six CAR-T therapies to carry boxed warning for secondary cancer; Sanofi buys Inhibrx for about US$ 2.2 billion
The US Food and Drug Administration (FDA) has mandated “black box” warnings on six major CAR-T cancer therapies ove...
Impressions : 2737

